Literature DB >> 12202725

Drug-induced pneumonitis: thin-section CT findings in 60 patients.

Masanori Akira1, Hideo Ishikawa, Satoru Yamamoto.   

Abstract

PURPOSE: To describe thin-section computed tomographic (CT) findings in patients with drug-induced pneumonitis, to compare these CT findings, and to correlate them with arterial oxygen tension level.
MATERIALS AND METHODS: Thin-section CT scans obtained in 60 patients with drug-induced pneumonitis were evaluated retrospectively. The patients had 31 cases of antineoplastic agent-induced pneumonitis and 29 cases of nonneoplastic agent-induced pneumonitis (antibiotic agent, 20 cases; herbal medicine [sho-saiko-to], four cases; antirheumatic agent, three cases; phenytoin, one case; disodium cromoglycate, one case). CT scans were reviewed by two chest radiologists in consensus. Correlation between arterial oxygen tension level and the extent of disease at CT was available in 21 patients. These two factors were compared by using the Spearman rank correlation coefficient.
RESULTS: The predominant findings in antineoplastic agent-induced pneumonitis were diffuse or multifocal ground-glass opacities with intralobular interstitial thickening. The predominant CT findings in antibiotic agent-induced pneumonitis were patchy ground-glass opacities with centrilobular opacities and interlobular septal lines. The predominant CT findings in herbal medicine-induced pneumonitis were diffuse ground-glass opacities with patchy consolidation. Interlobular septal lines and centrilobular opacities were observed more frequently in antibiotic agent-induced pneumonitis, and intralobular interstitial thickening was observed more frequently in antineoplastic agent-induced pneumonitis. A significant correlation was established between arterial oxygen tension level and extent of disease at CT (r = -0.84, P <.05).
CONCLUSION: In addition to ground-glass opacities and interlobular septal lines, the most common thin-section CT findings were intralobular interstitial thickening, observed in antineoplastic agent-induced pneumonitis, and centrilobular opacities, observed in antibiotic-induced pneumonitis. Copyright RSNA, 2002

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12202725     DOI: 10.1148/radiol.2243011236

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  23 in total

1.  Interstitial lung disease in patients with non-small-cell lung cancer treated with epidermal growth factor receptor inhibitors.

Authors:  Masahiro Tsuboi; Thierry Le Chevalier
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

2.  Exacerbation of radiation fibrosis with erlotinib: another pattern of radiation recall phenomenon.

Authors:  Hiroaki Arakawa; Takeshi Johkoh; Fumikazu Sakai; Masahiko Kusumoto; Osamu Hataji; Osamu Taguchi
Journal:  Jpn J Radiol       Date:  2011-09-17       Impact factor: 2.374

Review 3.  Drug-induced interstitial lung disease in molecular targeted therapies: high-resolution CT findings.

Authors:  Fumikazu Sakai; Takeshi Johkoh; Masahiko Kusumoto; Hiroaki Arakawa; Masahiro Takahashi
Journal:  Int J Clin Oncol       Date:  2012-11-10       Impact factor: 3.402

4.  Prospective evaluation of drug-induced lung toxicity with high-resolution CT and transbronchial biopsy.

Authors:  S Piciucchi; M Romagnoli; M Chilosi; C Bigliazzi; A Dubini; B Beomonte Zobel; G Gavelli; A Carloni; V Poletti
Journal:  Radiol Med       Date:  2010-12-03       Impact factor: 3.469

5.  Radiologic evaluation of pulmonary injury following carmustine- and cyclophosphamide-based preparative regimen for autologous peripheral blood stem cell transplantation in children.

Authors:  Yu Jin Kim; Woo Sun Kim; Young Hun Choi; Jung-Eun Cheon; Jung Yoon Choi; Hyoung Jin Kang; Ji-Eun Park; Young Jin Ryu; In-One Kim
Journal:  Pediatr Radiol       Date:  2018-08-18

6.  Successful Use of Afatinib After Erlotinib-induced Pneumonitis in a Patient With Epidermal Growth Factor Receptor-mutant Lung Cancer.

Authors:  Christopher D Jakubowski; Andrew J Plodkowski; Jason C Chang; Natasha Rekhtman; Afsheen Iqbal; Paul K Paik; Helena A Yu
Journal:  Clin Lung Cancer       Date:  2016-10-26       Impact factor: 4.785

7.  Diffuse interstitial infiltrative lung metastasis of malignant melanoma: a case report.

Authors:  Na-Young Shin; Yoo Jin Hong; Ah Hyun Kim; Hyo Sub Shim; Ji-Eun Nam; Hye-Jeong Lee; Myung-Joon Kim
Journal:  Korean J Radiol       Date:  2011-03-03       Impact factor: 3.500

Review 8.  Immune Checkpoint Immunotherapy for Non-Small Cell Lung Cancer: Benefits and Pulmonary Toxicities.

Authors:  Karthik Suresh; Jarushka Naidoo; Cheng Ting Lin; Sonye Danoff
Journal:  Chest       Date:  2018-09-04       Impact factor: 9.410

9.  Reversible lansoprazole-induced interstitial lung disease showing improvement after drug cessation.

Authors:  Kyu-won Hwang; Ok Hee Woo; Hwan Seok Yong; Bong Kyung Shin; Jae Jeong Shim; Eun-Young Kang
Journal:  Korean J Radiol       Date:  2008 Mar-Apr       Impact factor: 3.500

Review 10.  Interstitial lung disease associated with drug therapy.

Authors:  P Camus; S Kudoh; M Ebina
Journal:  Br J Cancer       Date:  2004-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.